nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—CYP2A6—Methoxsalen—hematologic cancer	0.11	0.4	CbGbCtD
Amobarbital—CYP2A6—Ifosfamide—hematologic cancer	0.08	0.291	CbGbCtD
Amobarbital—CYP2A6—Prednisolone—hematologic cancer	0.0533	0.194	CbGbCtD
Amobarbital—CHRFAM7A—ovarian follicle—hematologic cancer	0.0483	0.365	CbGeAlD
Amobarbital—CHRNA7—ovarian follicle—hematologic cancer	0.039	0.295	CbGeAlD
Amobarbital—CYP2A6—Dexamethasone—hematologic cancer	0.0314	0.115	CbGbCtD
Amobarbital—CHRFAM7A—hematopoietic system—hematologic cancer	0.00584	0.0441	CbGeAlD
Amobarbital—CHRNA7—hematopoietic system—hematologic cancer	0.00471	0.0356	CbGeAlD
Amobarbital—CHRNA4—hematopoietic system—hematologic cancer	0.00465	0.0351	CbGeAlD
Amobarbital—CHRFAM7A—blood—hematologic cancer	0.00387	0.0292	CbGeAlD
Amobarbital—GRIA2—testis—hematologic cancer	0.00351	0.0265	CbGeAlD
Amobarbital—GABRA5—testis—hematologic cancer	0.00329	0.0249	CbGeAlD
Amobarbital—CHRFAM7A—testis—hematologic cancer	0.0032	0.0242	CbGeAlD
Amobarbital—CHRNA7—blood—hematologic cancer	0.00312	0.0236	CbGeAlD
Amobarbital—GABRA3—testis—hematologic cancer	0.00306	0.0231	CbGeAlD
Amobarbital—CYP2A6—lung—hematologic cancer	0.00274	0.0207	CbGeAlD
Amobarbital—CHRNA4—lung—hematologic cancer	0.0027	0.0204	CbGeAlD
Amobarbital—CHRNA7—testis—hematologic cancer	0.00258	0.0195	CbGeAlD
Amobarbital—GABRA2—lymph node—hematologic cancer	0.00165	0.0125	CbGeAlD
Amobarbital—Dizziness—Hydroxyurea—hematologic cancer	0.000333	0.000701	CcSEcCtD
Amobarbital—Feeling abnormal—Alitretinoin—hematologic cancer	0.000332	0.0007	CcSEcCtD
Amobarbital—Constipation—Vincristine—hematologic cancer	0.000332	0.0007	CcSEcCtD
Amobarbital—Rash—Melphalan—hematologic cancer	0.000331	0.000697	CcSEcCtD
Amobarbital—Dermatitis—Melphalan—hematologic cancer	0.000331	0.000697	CcSEcCtD
Amobarbital—Feeling abnormal—Ifosfamide—hematologic cancer	0.000329	0.000692	CcSEcCtD
Amobarbital—Nausea—Vinblastine—hematologic cancer	0.000328	0.000691	CcSEcCtD
Amobarbital—Somnolence—Gemcitabine—hematologic cancer	0.000328	0.00069	CcSEcCtD
Amobarbital—Vomiting—Lenalidomide—hematologic cancer	0.000325	0.000684	CcSEcCtD
Amobarbital—Constipation—Irinotecan—hematologic cancer	0.000324	0.000682	CcSEcCtD
Amobarbital—Constipation—Mitoxantrone—hematologic cancer	0.000324	0.000682	CcSEcCtD
Amobarbital—Bradycardia—Prednisone—hematologic cancer	0.000323	0.000681	CcSEcCtD
Amobarbital—Hypersensitivity—Thiotepa—hematologic cancer	0.000323	0.00068	CcSEcCtD
Amobarbital—Rash—Lenalidomide—hematologic cancer	0.000322	0.000678	CcSEcCtD
Amobarbital—Body temperature increased—Carmustine—hematologic cancer	0.000322	0.000678	CcSEcCtD
Amobarbital—Dermatitis—Lenalidomide—hematologic cancer	0.000322	0.000678	CcSEcCtD
Amobarbital—Hypotension—Cisplatin—hematologic cancer	0.000321	0.000676	CcSEcCtD
Amobarbital—Vomiting—Hydroxyurea—hematologic cancer	0.00032	0.000674	CcSEcCtD
Amobarbital—Headache—Lenalidomide—hematologic cancer	0.00032	0.000674	CcSEcCtD
Amobarbital—Angioedema—Triamcinolone—hematologic cancer	0.00032	0.000673	CcSEcCtD
Amobarbital—Body temperature increased—Alitretinoin—hematologic cancer	0.000319	0.000671	CcSEcCtD
Amobarbital—Rash—Hydroxyurea—hematologic cancer	0.000318	0.000669	CcSEcCtD
Amobarbital—Confusional state—Etoposide—hematologic cancer	0.000317	0.000668	CcSEcCtD
Amobarbital—Dermatitis—Hydroxyurea—hematologic cancer	0.000317	0.000668	CcSEcCtD
Amobarbital—Hallucination—Prednisone—hematologic cancer	0.000316	0.000665	CcSEcCtD
Amobarbital—Headache—Hydroxyurea—hematologic cancer	0.000316	0.000664	CcSEcCtD
Amobarbital—Constipation—Gemcitabine—hematologic cancer	0.000315	0.000664	CcSEcCtD
Amobarbital—Body temperature increased—Ifosfamide—hematologic cancer	0.000315	0.000664	CcSEcCtD
Amobarbital—Syncope—Triamcinolone—hematologic cancer	0.000314	0.000661	CcSEcCtD
Amobarbital—Ataxia—Doxorubicin—hematologic cancer	0.000312	0.000658	CcSEcCtD
Amobarbital—Hypersensitivity—Thalidomide—hematologic cancer	0.000312	0.000658	CcSEcCtD
Amobarbital—Nausea—Melphalan—hematologic cancer	0.000312	0.000657	CcSEcCtD
Amobarbital—Feeling abnormal—Irinotecan—hematologic cancer	0.000312	0.000657	CcSEcCtD
Amobarbital—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000312	0.000657	CcSEcCtD
Amobarbital—Dizziness—Bortezomib—hematologic cancer	0.000311	0.000655	CcSEcCtD
Amobarbital—Loss of consciousness—Triamcinolone—hematologic cancer	0.000308	0.000648	CcSEcCtD
Amobarbital—Body temperature increased—Vincristine—hematologic cancer	0.000307	0.000647	CcSEcCtD
Amobarbital—Shock—Prednisolone—hematologic cancer	0.000306	0.000643	CcSEcCtD
Amobarbital—Feeling abnormal—Gemcitabine—hematologic cancer	0.000304	0.00064	CcSEcCtD
Amobarbital—Dizziness—Vinorelbine—hematologic cancer	0.000304	0.000639	CcSEcCtD
Amobarbital—Nausea—Lenalidomide—hematologic cancer	0.000303	0.000639	CcSEcCtD
Amobarbital—Hypersensitivity—Carmustine—hematologic cancer	0.0003	0.000632	CcSEcCtD
Amobarbital—Body temperature increased—Mitoxantrone—hematologic cancer	0.000299	0.00063	CcSEcCtD
Amobarbital—Body temperature increased—Irinotecan—hematologic cancer	0.000299	0.00063	CcSEcCtD
Amobarbital—Nausea—Hydroxyurea—hematologic cancer	0.000299	0.00063	CcSEcCtD
Amobarbital—Vomiting—Bortezomib—hematologic cancer	0.000299	0.000629	CcSEcCtD
Amobarbital—Hypersensitivity—Alitretinoin—hematologic cancer	0.000297	0.000626	CcSEcCtD
Amobarbital—Vomiting—Bleomycin—hematologic cancer	0.000297	0.000625	CcSEcCtD
Amobarbital—Rash—Bortezomib—hematologic cancer	0.000296	0.000624	CcSEcCtD
Amobarbital—Dermatitis—Bortezomib—hematologic cancer	0.000296	0.000624	CcSEcCtD
Amobarbital—Headache—Bortezomib—hematologic cancer	0.000294	0.00062	CcSEcCtD
Amobarbital—Hypotension—Etoposide—hematologic cancer	0.000294	0.00062	CcSEcCtD
Amobarbital—Rash—Bleomycin—hematologic cancer	0.000294	0.000619	CcSEcCtD
Amobarbital—Dermatitis—Bleomycin—hematologic cancer	0.000294	0.000619	CcSEcCtD
Amobarbital—Hypersensitivity—Ifosfamide—hematologic cancer	0.000294	0.000618	CcSEcCtD
Amobarbital—Vomiting—Vinorelbine—hematologic cancer	0.000292	0.000614	CcSEcCtD
Amobarbital—Body temperature increased—Gemcitabine—hematologic cancer	0.000291	0.000614	CcSEcCtD
Amobarbital—Angioedema—Dexamethasone—hematologic cancer	0.00029	0.000611	CcSEcCtD
Amobarbital—Angioedema—Betamethasone—hematologic cancer	0.00029	0.000611	CcSEcCtD
Amobarbital—Dizziness—Thiotepa—hematologic cancer	0.00029	0.00061	CcSEcCtD
Amobarbital—Rash—Vinorelbine—hematologic cancer	0.000289	0.000609	CcSEcCtD
Amobarbital—Dermatitis—Vinorelbine—hematologic cancer	0.000289	0.000609	CcSEcCtD
Amobarbital—Headache—Vinorelbine—hematologic cancer	0.000288	0.000605	CcSEcCtD
Amobarbital—Hypersensitivity—Vincristine—hematologic cancer	0.000286	0.000603	CcSEcCtD
Amobarbital—Syncope—Dexamethasone—hematologic cancer	0.000285	0.0006	CcSEcCtD
Amobarbital—Syncope—Betamethasone—hematologic cancer	0.000285	0.0006	CcSEcCtD
Amobarbital—Feeling abnormal—Cisplatin—hematologic cancer	0.000283	0.000596	CcSEcCtD
Amobarbital—Shock—Triamcinolone—hematologic cancer	0.000281	0.000592	CcSEcCtD
Amobarbital—Dizziness—Thalidomide—hematologic cancer	0.00028	0.00059	CcSEcCtD
Amobarbital—Somnolence—Etoposide—hematologic cancer	0.00028	0.000589	CcSEcCtD
Amobarbital—Nausea—Bortezomib—hematologic cancer	0.000279	0.000588	CcSEcCtD
Amobarbital—Loss of consciousness—Dexamethasone—hematologic cancer	0.000279	0.000588	CcSEcCtD
Amobarbital—Loss of consciousness—Betamethasone—hematologic cancer	0.000279	0.000588	CcSEcCtD
Amobarbital—Hypersensitivity—Irinotecan—hematologic cancer	0.000279	0.000587	CcSEcCtD
Amobarbital—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000279	0.000587	CcSEcCtD
Amobarbital—Vomiting—Thiotepa—hematologic cancer	0.000279	0.000587	CcSEcCtD
Amobarbital—Nausea—Bleomycin—hematologic cancer	0.000277	0.000583	CcSEcCtD
Amobarbital—Rash—Thiotepa—hematologic cancer	0.000276	0.000582	CcSEcCtD
Amobarbital—Dermatitis—Thiotepa—hematologic cancer	0.000276	0.000581	CcSEcCtD
Amobarbital—Headache—Thiotepa—hematologic cancer	0.000275	0.000578	CcSEcCtD
Amobarbital—Nausea—Vinorelbine—hematologic cancer	0.000273	0.000574	CcSEcCtD
Amobarbital—Body temperature increased—Cisplatin—hematologic cancer	0.000272	0.000572	CcSEcCtD
Amobarbital—Vomiting—Thalidomide—hematologic cancer	0.00027	0.000568	CcSEcCtD
Amobarbital—Anxiety—Dexamethasone—hematologic cancer	0.000269	0.000567	CcSEcCtD
Amobarbital—Anxiety—Betamethasone—hematologic cancer	0.000269	0.000567	CcSEcCtD
Amobarbital—Dizziness—Carmustine—hematologic cancer	0.000269	0.000567	CcSEcCtD
Amobarbital—Constipation—Etoposide—hematologic cancer	0.000269	0.000567	CcSEcCtD
Amobarbital—Rash—Thalidomide—hematologic cancer	0.000267	0.000563	CcSEcCtD
Amobarbital—Dermatitis—Thalidomide—hematologic cancer	0.000267	0.000562	CcSEcCtD
Amobarbital—Dizziness—Alitretinoin—hematologic cancer	0.000267	0.000562	CcSEcCtD
Amobarbital—Headache—Thalidomide—hematologic cancer	0.000266	0.000559	CcSEcCtD
Amobarbital—Dizziness—Ifosfamide—hematologic cancer	0.000264	0.000555	CcSEcCtD
Amobarbital—Nausea—Thiotepa—hematologic cancer	0.00026	0.000548	CcSEcCtD
Amobarbital—Feeling abnormal—Etoposide—hematologic cancer	0.000259	0.000546	CcSEcCtD
Amobarbital—Vomiting—Carmustine—hematologic cancer	0.000259	0.000545	CcSEcCtD
Amobarbital—Dizziness—Vincristine—hematologic cancer	0.000257	0.000541	CcSEcCtD
Amobarbital—Rash—Carmustine—hematologic cancer	0.000257	0.000541	CcSEcCtD
Amobarbital—Dermatitis—Carmustine—hematologic cancer	0.000256	0.00054	CcSEcCtD
Amobarbital—Vomiting—Alitretinoin—hematologic cancer	0.000256	0.00054	CcSEcCtD
Amobarbital—Feeling abnormal—Prednisolone—hematologic cancer	0.000256	0.000539	CcSEcCtD
Amobarbital—Headache—Carmustine—hematologic cancer	0.000255	0.000537	CcSEcCtD
Amobarbital—Shock—Dexamethasone—hematologic cancer	0.000255	0.000537	CcSEcCtD
Amobarbital—Shock—Betamethasone—hematologic cancer	0.000255	0.000537	CcSEcCtD
Amobarbital—Rash—Alitretinoin—hematologic cancer	0.000254	0.000536	CcSEcCtD
Amobarbital—Agitation—Prednisone—hematologic cancer	0.000254	0.000535	CcSEcCtD
Amobarbital—Dermatitis—Alitretinoin—hematologic cancer	0.000254	0.000535	CcSEcCtD
Amobarbital—Vomiting—Ifosfamide—hematologic cancer	0.000253	0.000534	CcSEcCtD
Amobarbital—Hypersensitivity—Cisplatin—hematologic cancer	0.000253	0.000533	CcSEcCtD
Amobarbital—Bradycardia—Epirubicin—hematologic cancer	0.000253	0.000533	CcSEcCtD
Amobarbital—Headache—Alitretinoin—hematologic cancer	0.000253	0.000532	CcSEcCtD
Amobarbital—Angioedema—Prednisone—hematologic cancer	0.000253	0.000532	CcSEcCtD
Amobarbital—Nausea—Thalidomide—hematologic cancer	0.000252	0.00053	CcSEcCtD
Amobarbital—Rash—Ifosfamide—hematologic cancer	0.000251	0.000529	CcSEcCtD
Amobarbital—Dermatitis—Ifosfamide—hematologic cancer	0.000251	0.000529	CcSEcCtD
Amobarbital—Dizziness—Irinotecan—hematologic cancer	0.00025	0.000527	CcSEcCtD
Amobarbital—Body temperature increased—Etoposide—hematologic cancer	0.000249	0.000524	CcSEcCtD
Amobarbital—Syncope—Prednisone—hematologic cancer	0.000248	0.000522	CcSEcCtD
Amobarbital—Vomiting—Vincristine—hematologic cancer	0.000247	0.00052	CcSEcCtD
Amobarbital—Rash—Vincristine—hematologic cancer	0.000245	0.000516	CcSEcCtD
Amobarbital—Dermatitis—Vincristine—hematologic cancer	0.000245	0.000516	CcSEcCtD
Amobarbital—Headache—Vincristine—hematologic cancer	0.000244	0.000513	CcSEcCtD
Amobarbital—Loss of consciousness—Prednisone—hematologic cancer	0.000243	0.000512	CcSEcCtD
Amobarbital—Hypotension—Betamethasone—hematologic cancer	0.000242	0.00051	CcSEcCtD
Amobarbital—Hypotension—Dexamethasone—hematologic cancer	0.000242	0.00051	CcSEcCtD
Amobarbital—Nausea—Carmustine—hematologic cancer	0.000242	0.000509	CcSEcCtD
Amobarbital—Vomiting—Mitoxantrone—hematologic cancer	0.000241	0.000507	CcSEcCtD
Amobarbital—Vomiting—Irinotecan—hematologic cancer	0.000241	0.000507	CcSEcCtD
Amobarbital—Nausea—Alitretinoin—hematologic cancer	0.00024	0.000505	CcSEcCtD
Amobarbital—Rash—Mitoxantrone—hematologic cancer	0.000239	0.000503	CcSEcCtD
Amobarbital—Rash—Irinotecan—hematologic cancer	0.000239	0.000503	CcSEcCtD
Amobarbital—Dermatitis—Mitoxantrone—hematologic cancer	0.000238	0.000502	CcSEcCtD
Amobarbital—Dermatitis—Irinotecan—hematologic cancer	0.000238	0.000502	CcSEcCtD
Amobarbital—Headache—Mitoxantrone—hematologic cancer	0.000237	0.000499	CcSEcCtD
Amobarbital—Headache—Irinotecan—hematologic cancer	0.000237	0.000499	CcSEcCtD
Amobarbital—Nausea—Ifosfamide—hematologic cancer	0.000237	0.000499	CcSEcCtD
Amobarbital—Feeling abnormal—Triamcinolone—hematologic cancer	0.000235	0.000496	CcSEcCtD
Amobarbital—Anxiety—Prednisone—hematologic cancer	0.000235	0.000494	CcSEcCtD
Amobarbital—Vomiting—Gemcitabine—hematologic cancer	0.000234	0.000494	CcSEcCtD
Amobarbital—Bradycardia—Doxorubicin—hematologic cancer	0.000234	0.000493	CcSEcCtD
Amobarbital—Rash—Gemcitabine—hematologic cancer	0.000232	0.00049	CcSEcCtD
Amobarbital—Dermatitis—Gemcitabine—hematologic cancer	0.000232	0.000489	CcSEcCtD
Amobarbital—Hypersensitivity—Etoposide—hematologic cancer	0.000232	0.000488	CcSEcCtD
Amobarbital—Headache—Gemcitabine—hematologic cancer	0.000231	0.000486	CcSEcCtD
Amobarbital—Nausea—Vincristine—hematologic cancer	0.000231	0.000486	CcSEcCtD
Amobarbital—Hypersensitivity—Prednisolone—hematologic cancer	0.000229	0.000482	CcSEcCtD
Amobarbital—Body temperature increased—Triamcinolone—hematologic cancer	0.000226	0.000475	CcSEcCtD
Amobarbital—Nausea—Mitoxantrone—hematologic cancer	0.000225	0.000473	CcSEcCtD
Amobarbital—Nausea—Irinotecan—hematologic cancer	0.000225	0.000473	CcSEcCtD
Amobarbital—Shock—Prednisone—hematologic cancer	0.000222	0.000467	CcSEcCtD
Amobarbital—Nausea—Gemcitabine—hematologic cancer	0.000219	0.000461	CcSEcCtD
Amobarbital—Vomiting—Cisplatin—hematologic cancer	0.000219	0.00046	CcSEcCtD
Amobarbital—Rash—Cisplatin—hematologic cancer	0.000217	0.000456	CcSEcCtD
Amobarbital—Dermatitis—Cisplatin—hematologic cancer	0.000217	0.000456	CcSEcCtD
Amobarbital—Feeling abnormal—Betamethasone—hematologic cancer	0.000214	0.00045	CcSEcCtD
Amobarbital—Feeling abnormal—Dexamethasone—hematologic cancer	0.000214	0.00045	CcSEcCtD
Amobarbital—Tension—Epirubicin—hematologic cancer	0.000212	0.000447	CcSEcCtD
Amobarbital—Hypersensitivity—Triamcinolone—hematologic cancer	0.00021	0.000443	CcSEcCtD
Amobarbital—Nervousness—Epirubicin—hematologic cancer	0.00021	0.000442	CcSEcCtD
Amobarbital—Dizziness—Etoposide—hematologic cancer	0.000208	0.000438	CcSEcCtD
Amobarbital—Dizziness—Prednisolone—hematologic cancer	0.000205	0.000432	CcSEcCtD
Amobarbital—Body temperature increased—Betamethasone—hematologic cancer	0.000205	0.000431	CcSEcCtD
Amobarbital—Body temperature increased—Dexamethasone—hematologic cancer	0.000205	0.000431	CcSEcCtD
Amobarbital—Nausea—Cisplatin—hematologic cancer	0.000204	0.00043	CcSEcCtD
Amobarbital—Vomiting—Etoposide—hematologic cancer	0.0002	0.000422	CcSEcCtD
Amobarbital—Agitation—Epirubicin—hematologic cancer	0.000199	0.000418	CcSEcCtD
Amobarbital—Rash—Etoposide—hematologic cancer	0.000199	0.000418	CcSEcCtD
Amobarbital—Dermatitis—Etoposide—hematologic cancer	0.000198	0.000418	CcSEcCtD
Amobarbital—Headache—Etoposide—hematologic cancer	0.000197	0.000415	CcSEcCtD
Amobarbital—Tension—Doxorubicin—hematologic cancer	0.000196	0.000413	CcSEcCtD
Amobarbital—Rash—Prednisolone—hematologic cancer	0.000196	0.000412	CcSEcCtD
Amobarbital—Dermatitis—Prednisolone—hematologic cancer	0.000196	0.000412	CcSEcCtD
Amobarbital—Headache—Prednisolone—hematologic cancer	0.000195	0.00041	CcSEcCtD
Amobarbital—Nervousness—Doxorubicin—hematologic cancer	0.000194	0.000409	CcSEcCtD
Amobarbital—Syncope—Epirubicin—hematologic cancer	0.000194	0.000408	CcSEcCtD
Amobarbital—Constipation—Prednisone—hematologic cancer	0.000193	0.000406	CcSEcCtD
Amobarbital—Confusional state—Methotrexate—hematologic cancer	0.00019	0.0004	CcSEcCtD
Amobarbital—Loss of consciousness—Epirubicin—hematologic cancer	0.00019	0.0004	CcSEcCtD
Amobarbital—Dizziness—Triamcinolone—hematologic cancer	0.000189	0.000398	CcSEcCtD
Amobarbital—Nausea—Etoposide—hematologic cancer	0.000187	0.000394	CcSEcCtD
Amobarbital—Feeling abnormal—Prednisone—hematologic cancer	0.000186	0.000392	CcSEcCtD
Amobarbital—Nausea—Prednisolone—hematologic cancer	0.000184	0.000388	CcSEcCtD
Amobarbital—Agitation—Doxorubicin—hematologic cancer	0.000184	0.000387	CcSEcCtD
Amobarbital—Anxiety—Epirubicin—hematologic cancer	0.000183	0.000386	CcSEcCtD
Amobarbital—Vomiting—Triamcinolone—hematologic cancer	0.000182	0.000382	CcSEcCtD
Amobarbital—Rash—Triamcinolone—hematologic cancer	0.00018	0.000379	CcSEcCtD
Amobarbital—Dermatitis—Triamcinolone—hematologic cancer	0.00018	0.000379	CcSEcCtD
Amobarbital—Syncope—Doxorubicin—hematologic cancer	0.000179	0.000378	CcSEcCtD
Amobarbital—Headache—Triamcinolone—hematologic cancer	0.000179	0.000377	CcSEcCtD
Amobarbital—Body temperature increased—Prednisone—hematologic cancer	0.000178	0.000376	CcSEcCtD
Amobarbital—Confusional state—Epirubicin—hematologic cancer	0.000178	0.000375	CcSEcCtD
Amobarbital—Hypotension—Methotrexate—hematologic cancer	0.000176	0.000371	CcSEcCtD
Amobarbital—Loss of consciousness—Doxorubicin—hematologic cancer	0.000176	0.00037	CcSEcCtD
Amobarbital—Shock—Epirubicin—hematologic cancer	0.000174	0.000366	CcSEcCtD
Amobarbital—Dizziness—Betamethasone—hematologic cancer	0.000171	0.000361	CcSEcCtD
Amobarbital—Dizziness—Dexamethasone—hematologic cancer	0.000171	0.000361	CcSEcCtD
Amobarbital—Anxiety—Doxorubicin—hematologic cancer	0.00017	0.000357	CcSEcCtD
Amobarbital—Nausea—Triamcinolone—hematologic cancer	0.00017	0.000357	CcSEcCtD
Amobarbital—Somnolence—Methotrexate—hematologic cancer	0.000168	0.000353	CcSEcCtD
Amobarbital—Hypersensitivity—Prednisone—hematologic cancer	0.000166	0.00035	CcSEcCtD
Amobarbital—Hypotension—Epirubicin—hematologic cancer	0.000165	0.000347	CcSEcCtD
Amobarbital—Vomiting—Betamethasone—hematologic cancer	0.000165	0.000347	CcSEcCtD
Amobarbital—Vomiting—Dexamethasone—hematologic cancer	0.000165	0.000347	CcSEcCtD
Amobarbital—Confusional state—Doxorubicin—hematologic cancer	0.000165	0.000347	CcSEcCtD
Amobarbital—Rash—Betamethasone—hematologic cancer	0.000163	0.000344	CcSEcCtD
Amobarbital—Rash—Dexamethasone—hematologic cancer	0.000163	0.000344	CcSEcCtD
Amobarbital—Dermatitis—Dexamethasone—hematologic cancer	0.000163	0.000344	CcSEcCtD
Amobarbital—Dermatitis—Betamethasone—hematologic cancer	0.000163	0.000344	CcSEcCtD
Amobarbital—Headache—Dexamethasone—hematologic cancer	0.000162	0.000342	CcSEcCtD
Amobarbital—Headache—Betamethasone—hematologic cancer	0.000162	0.000342	CcSEcCtD
Amobarbital—Shock—Doxorubicin—hematologic cancer	0.000161	0.000338	CcSEcCtD
Amobarbital—Somnolence—Epirubicin—hematologic cancer	0.000157	0.00033	CcSEcCtD
Amobarbital—Feeling abnormal—Methotrexate—hematologic cancer	0.000155	0.000327	CcSEcCtD
Amobarbital—Nausea—Dexamethasone—hematologic cancer	0.000154	0.000324	CcSEcCtD
Amobarbital—Nausea—Betamethasone—hematologic cancer	0.000154	0.000324	CcSEcCtD
Amobarbital—Hypotension—Doxorubicin—hematologic cancer	0.000153	0.000321	CcSEcCtD
Amobarbital—Constipation—Epirubicin—hematologic cancer	0.000151	0.000318	CcSEcCtD
Amobarbital—Dizziness—Prednisone—hematologic cancer	0.000149	0.000314	CcSEcCtD
Amobarbital—Body temperature increased—Methotrexate—hematologic cancer	0.000149	0.000314	CcSEcCtD
Amobarbital—Feeling abnormal—Epirubicin—hematologic cancer	0.000145	0.000306	CcSEcCtD
Amobarbital—Somnolence—Doxorubicin—hematologic cancer	0.000145	0.000306	CcSEcCtD
Amobarbital—Vomiting—Prednisone—hematologic cancer	0.000143	0.000302	CcSEcCtD
Amobarbital—Rash—Prednisone—hematologic cancer	0.000142	0.0003	CcSEcCtD
Amobarbital—Dermatitis—Prednisone—hematologic cancer	0.000142	0.000299	CcSEcCtD
Amobarbital—Headache—Prednisone—hematologic cancer	0.000141	0.000298	CcSEcCtD
Amobarbital—Constipation—Doxorubicin—hematologic cancer	0.00014	0.000294	CcSEcCtD
Amobarbital—Body temperature increased—Epirubicin—hematologic cancer	0.00014	0.000294	CcSEcCtD
Amobarbital—Hypersensitivity—Methotrexate—hematologic cancer	0.000139	0.000293	CcSEcCtD
Amobarbital—Feeling abnormal—Doxorubicin—hematologic cancer	0.000135	0.000283	CcSEcCtD
Amobarbital—Nausea—Prednisone—hematologic cancer	0.000134	0.000282	CcSEcCtD
Amobarbital—Hypersensitivity—Epirubicin—hematologic cancer	0.00013	0.000274	CcSEcCtD
Amobarbital—Body temperature increased—Doxorubicin—hematologic cancer	0.000129	0.000272	CcSEcCtD
Amobarbital—Dizziness—Methotrexate—hematologic cancer	0.000125	0.000263	CcSEcCtD
Amobarbital—Hypersensitivity—Doxorubicin—hematologic cancer	0.00012	0.000253	CcSEcCtD
Amobarbital—Vomiting—Methotrexate—hematologic cancer	0.00012	0.000252	CcSEcCtD
Amobarbital—Rash—Methotrexate—hematologic cancer	0.000119	0.00025	CcSEcCtD
Amobarbital—Dermatitis—Methotrexate—hematologic cancer	0.000119	0.00025	CcSEcCtD
Amobarbital—Headache—Methotrexate—hematologic cancer	0.000118	0.000249	CcSEcCtD
Amobarbital—Dizziness—Epirubicin—hematologic cancer	0.000117	0.000246	CcSEcCtD
Amobarbital—Vomiting—Epirubicin—hematologic cancer	0.000112	0.000236	CcSEcCtD
Amobarbital—Nausea—Methotrexate—hematologic cancer	0.000112	0.000236	CcSEcCtD
Amobarbital—Rash—Epirubicin—hematologic cancer	0.000111	0.000234	CcSEcCtD
Amobarbital—Dermatitis—Epirubicin—hematologic cancer	0.000111	0.000234	CcSEcCtD
Amobarbital—Headache—Epirubicin—hematologic cancer	0.000111	0.000233	CcSEcCtD
Amobarbital—Dizziness—Doxorubicin—hematologic cancer	0.000108	0.000227	CcSEcCtD
Amobarbital—Nausea—Epirubicin—hematologic cancer	0.000105	0.000221	CcSEcCtD
Amobarbital—Vomiting—Doxorubicin—hematologic cancer	0.000104	0.000219	CcSEcCtD
Amobarbital—Rash—Doxorubicin—hematologic cancer	0.000103	0.000217	CcSEcCtD
Amobarbital—Dermatitis—Doxorubicin—hematologic cancer	0.000103	0.000217	CcSEcCtD
Amobarbital—Headache—Doxorubicin—hematologic cancer	0.000102	0.000215	CcSEcCtD
Amobarbital—CYP2A6—NRF2 pathway—GSTM1—hematologic cancer	0.000101	0.00085	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.0001	0.000844	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	9.96e-05	0.000841	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—CREB1—hematologic cancer	9.96e-05	0.000841	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	9.88e-05	0.000834	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—BRAF—hematologic cancer	9.84e-05	0.00083	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	9.81e-05	0.000828	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	9.8e-05	0.000827	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SGK1—hematologic cancer	9.8e-05	0.000827	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	9.8e-05	0.000827	CbGpPWpGaD
Amobarbital—Nausea—Doxorubicin—hematologic cancer	9.7e-05	0.000204	CcSEcCtD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	9.69e-05	0.000818	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK8—hematologic cancer	9.67e-05	0.000816	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTP1—hematologic cancer	9.61e-05	0.000811	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—hematologic cancer	9.59e-05	0.00081	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—hematologic cancer	9.57e-05	0.000808	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.41e-05	0.000794	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—PRKCG—hematologic cancer	9.4e-05	0.000794	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—hematologic cancer	9.3e-05	0.000785	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—PRKCG—hematologic cancer	9.28e-05	0.000784	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—NUP98—hematologic cancer	9.26e-05	0.000782	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.24e-05	0.00078	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—SRC—hematologic cancer	9.17e-05	0.000774	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—NUP98—hematologic cancer	9.14e-05	0.000772	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—CREB1—hematologic cancer	9.09e-05	0.000767	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.08e-05	0.000767	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—MDM2—hematologic cancer	9.06e-05	0.000765	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—MDM2—hematologic cancer	9.04e-05	0.000763	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	8.99e-05	0.000759	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—BRAF—hematologic cancer	8.97e-05	0.000758	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—CREB1—hematologic cancer	8.97e-05	0.000758	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—NUP214—hematologic cancer	8.92e-05	0.000753	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ADCY7—hematologic cancer	8.87e-05	0.000749	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—BRAF—hematologic cancer	8.86e-05	0.000748	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	8.86e-05	0.000748	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—STAT3—hematologic cancer	8.84e-05	0.000746	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTM1—hematologic cancer	8.83e-05	0.000745	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	8.82e-05	0.000745	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—NUP214—hematologic cancer	8.81e-05	0.000744	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	8.78e-05	0.000741	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—hematologic cancer	8.77e-05	0.00074	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	8.74e-05	0.000738	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	8.73e-05	0.000737	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—PDGFB—hematologic cancer	8.66e-05	0.000731	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ABCG2—hematologic cancer	8.63e-05	0.000729	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	8.63e-05	0.000729	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	8.62e-05	0.000728	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	8.62e-05	0.000727	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.61e-05	0.000727	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—hematologic cancer	8.58e-05	0.000724	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—hematologic cancer	8.54e-05	0.000721	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	8.47e-05	0.000715	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.45e-05	0.000713	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK3—hematologic cancer	8.45e-05	0.000713	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—CREB1—hematologic cancer	8.37e-05	0.000707	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.3e-05	0.000701	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—BRAF—hematologic cancer	8.27e-05	0.000698	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—PRKCG—hematologic cancer	8.25e-05	0.000696	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—MDM2—hematologic cancer	8.24e-05	0.000696	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	8.12e-05	0.000686	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—NUP98—hematologic cancer	8.12e-05	0.000686	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—CREB1—hematologic cancer	8.12e-05	0.000686	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—PRKCG—hematologic cancer	8.1e-05	0.000684	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—BRAF—hematologic cancer	8.02e-05	0.000677	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	8e-05	0.000676	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.98e-05	0.000673	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—CREB1—hematologic cancer	7.97e-05	0.000673	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—PRKCG—hematologic cancer	7.96e-05	0.000672	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.88e-05	0.000666	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—BRAF—hematologic cancer	7.87e-05	0.000665	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	7.85e-05	0.000663	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.84e-05	0.000662	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—CREB1—hematologic cancer	7.83e-05	0.000661	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.83e-05	0.000661	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	7.81e-05	0.000659	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	7.8e-05	0.000658	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—TFRC—hematologic cancer	7.79e-05	0.000658	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	7.74e-05	0.000654	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.74e-05	0.000654	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—BRAF—hematologic cancer	7.73e-05	0.000653	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—CREB1—hematologic cancer	7.69e-05	0.00065	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—TFRC—hematologic cancer	7.69e-05	0.00065	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.69e-05	0.000649	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.67e-05	0.000648	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.61e-05	0.000642	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—BRAF—hematologic cancer	7.6e-05	0.000641	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.56e-05	0.000638	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.53e-05	0.000636	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—MDM2—hematologic cancer	7.52e-05	0.000635	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—MDM2—hematologic cancer	7.42e-05	0.000627	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.4e-05	0.000625	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PHYH—hematologic cancer	7.36e-05	0.000621	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GMPS—hematologic cancer	7.36e-05	0.000621	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—FTCD—hematologic cancer	7.36e-05	0.000621	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	7.22e-05	0.00061	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	7.08e-05	0.000598	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—CREB1—hematologic cancer	6.96e-05	0.000588	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.96e-05	0.000588	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—MDM2—hematologic cancer	6.93e-05	0.000585	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—hematologic cancer	6.89e-05	0.000582	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—BRAF—hematologic cancer	6.88e-05	0.00058	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—CREB1—hematologic cancer	6.88e-05	0.00058	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.84e-05	0.000577	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—BRAF—hematologic cancer	6.79e-05	0.000573	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—PRKCG—hematologic cancer	6.79e-05	0.000573	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SMPD3—hematologic cancer	6.73e-05	0.000568	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—MDM2—hematologic cancer	6.72e-05	0.000567	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.71e-05	0.000567	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.68e-05	0.000564	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.6e-05	0.000557	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.6e-05	0.000557	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—MDM2—hematologic cancer	6.6e-05	0.000557	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—CREB1—hematologic cancer	6.56e-05	0.000554	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.54e-05	0.000552	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.49e-05	0.000548	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.49e-05	0.000548	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—hematologic cancer	6.48e-05	0.000547	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—MDM2—hematologic cancer	6.48e-05	0.000547	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.46e-05	0.000545	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—HRAS—hematologic cancer	6.45e-05	0.000545	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.44e-05	0.000544	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	6.4e-05	0.00054	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—MDM2—hematologic cancer	6.37e-05	0.000537	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.31e-05	0.000533	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—CREB1—hematologic cancer	6.11e-05	0.000516	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—BRAF—hematologic cancer	6.03e-05	0.000509	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—CREB1—hematologic cancer	6e-05	0.000506	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	5.94e-05	0.000501	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	5.93e-05	0.0005	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—BRAF—hematologic cancer	5.92e-05	0.0005	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.9e-05	0.000498	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—CREB1—hematologic cancer	5.9e-05	0.000498	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—DCK—hematologic cancer	5.88e-05	0.000497	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—B3GAT1—hematologic cancer	5.88e-05	0.000497	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ASNS—hematologic cancer	5.88e-05	0.000497	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—BRAF—hematologic cancer	5.82e-05	0.000491	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—MDM2—hematologic cancer	5.76e-05	0.000486	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—hematologic cancer	5.76e-05	0.000486	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.74e-05	0.000484	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—AKT1—hematologic cancer	5.7e-05	0.000481	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—MDM2—hematologic cancer	5.69e-05	0.00048	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.63e-05	0.000476	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.63e-05	0.000475	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—hematologic cancer	5.62e-05	0.000474	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HDC—hematologic cancer	5.58e-05	0.000471	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.54e-05	0.000467	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.49e-05	0.000463	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.46e-05	0.000461	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	5.43e-05	0.000458	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.42e-05	0.000458	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.39e-05	0.000455	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	5.31e-05	0.000448	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CDA—hematologic cancer	5.1e-05	0.000431	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—MDM2—hematologic cancer	5.05e-05	0.000427	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	5.03e-05	0.000425	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—CREB1—hematologic cancer	5.03e-05	0.000424	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—HRAS—hematologic cancer	4.97e-05	0.00042	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—BRAF—hematologic cancer	4.96e-05	0.000419	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—MDM2—hematologic cancer	4.96e-05	0.000419	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.96e-05	0.000419	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PC—hematologic cancer	4.91e-05	0.000415	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—MDM2—hematologic cancer	4.88e-05	0.000412	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	4.82e-05	0.000407	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.81e-05	0.000406	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.79e-05	0.000404	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GBA—hematologic cancer	4.74e-05	0.0004	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC35B2—hematologic cancer	4.74e-05	0.0004	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	4.73e-05	0.000399	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.72e-05	0.000399	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.7e-05	0.000397	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	4.65e-05	0.000392	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.62e-05	0.00039	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—HRAS—hematologic cancer	4.52e-05	0.000382	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTAP—hematologic cancer	4.34e-05	0.000366	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.31e-05	0.000364	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—MDM2—hematologic cancer	4.16e-05	0.000351	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.13e-05	0.000348	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—TGFB1—hematologic cancer	4.1e-05	0.000346	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.07e-05	0.000344	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.96e-05	0.000335	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.94e-05	0.000333	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—FHL2—hematologic cancer	3.87e-05	0.000326	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—HRAS—hematologic cancer	3.8e-05	0.000321	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AGRN—hematologic cancer	3.79e-05	0.00032	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—HRAS—hematologic cancer	3.69e-05	0.000311	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.65e-05	0.000308	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.62e-05	0.000306	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.6e-05	0.000304	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HMMR—hematologic cancer	3.59e-05	0.000303	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—IDH2—hematologic cancer	3.59e-05	0.000303	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.55e-05	0.0003	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.49e-05	0.000295	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.48e-05	0.000294	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ALB—hematologic cancer	3.41e-05	0.000288	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ARNTL—hematologic cancer	3.38e-05	0.000285	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ALB—hematologic cancer	3.37e-05	0.000285	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ACP5—hematologic cancer	3.29e-05	0.000278	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CA9—hematologic cancer	3.29e-05	0.000278	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOR2—hematologic cancer	3.24e-05	0.000274	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.2e-05	0.00027	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—HRAS—hematologic cancer	3.16e-05	0.000267	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.14e-05	0.000265	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—HRAS—hematologic cancer	3.12e-05	0.000264	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—IDH1—hematologic cancer	3.09e-05	0.000261	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.09e-05	0.000261	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TXN—hematologic cancer	3.06e-05	0.000258	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ABCC3—hematologic cancer	3.06e-05	0.000258	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTO1—hematologic cancer	3.06e-05	0.000258	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	2.99e-05	0.000253	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SPHK1—hematologic cancer	2.99e-05	0.000253	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.98e-05	0.000251	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.94e-05	0.000248	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.89e-05	0.000244	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—UGT1A1—hematologic cancer	2.87e-05	0.000243	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC22A1—hematologic cancer	2.8e-05	0.000236	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CRABP1—hematologic cancer	2.8e-05	0.000236	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—HRAS—hematologic cancer	2.77e-05	0.000234	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALOX5—hematologic cancer	2.72e-05	0.00023	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—HRAS—hematologic cancer	2.72e-05	0.00023	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—HRAS—hematologic cancer	2.68e-05	0.000226	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NUP98—hematologic cancer	2.64e-05	0.000223	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.63e-05	0.000222	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ADCY7—hematologic cancer	2.56e-05	0.000216	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOA3—hematologic cancer	2.56e-05	0.000216	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NUP214—hematologic cancer	2.54e-05	0.000215	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ABCG2—hematologic cancer	2.49e-05	0.00021	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTR—hematologic cancer	2.49e-05	0.00021	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.46e-05	0.000208	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ENO2—hematologic cancer	2.44e-05	0.000206	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTT1—hematologic cancer	2.37e-05	0.0002	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SDC1—hematologic cancer	2.32e-05	0.000196	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—HRAS—hematologic cancer	2.28e-05	0.000193	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CD44—hematologic cancer	1.97e-05	0.000166	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NQO1—hematologic cancer	1.97e-05	0.000166	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYCS—hematologic cancer	1.86e-05	0.000157	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	1.85e-05	0.000156	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTP1—hematologic cancer	1.64e-05	0.000139	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ABCB1—hematologic cancer	1.56e-05	0.000131	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOR1—hematologic cancer	1.51e-05	0.000127	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTM1—hematologic cancer	1.51e-05	0.000127	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTHFR—hematologic cancer	1.33e-05	0.000113	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CG—hematologic cancer	1.12e-05	9.46e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CREBBP—hematologic cancer	1.04e-05	8.77e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CD—hematologic cancer	9.85e-06	8.32e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALB—hematologic cancer	9.73e-06	8.21e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3R1—hematologic cancer	9.31e-06	7.86e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CB—hematologic cancer	8.59e-06	7.25e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTEN—hematologic cancer	7.42e-06	6.27e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—EP300—hematologic cancer	7.08e-06	5.98e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CA—hematologic cancer	5.24e-06	4.42e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKT1—hematologic cancer	4.28e-06	3.61e-05	CbGpPWpGaD
